Retinalgenix Technologies INC 10-Q quarterly reports

RetinalGenix Technologies reports a net loss of $590,489 for Q1 2026 while highlighting ongoing liquidity challenges and a going concern warning.

RetinalGenix Technologies Inc. reported a reduced net loss for Q3 2025, but faces significant liquidity challenges and a going concern warning, necessitating substantial additional capital.

RetinalGenix Technologies Inc. reported continued significant net losses and a critical cash shortage for Q2 2025, raising substantial doubt about its ability to continue as a going concern without immediate capital infusion.

RetinalGenix Technologies Inc. reported a net loss of $1.24 million for the first half of 2025, with minimal cash and substantial doubt about its ability to continue as a going concern.

RetinalGenix Technologies reports no revenue and a net loss of $587,259 for Q1 2025, with substantial doubt about its ability to continue as a going concern.

RetinalGenix Technologies reports a net loss of $3.45 million for the nine months ended September 30, 2024, and expresses substantial doubt about its ability to continue as a going concern.

RetinalGenix Technologies reported a significant increase in net loss for the second quarter of 2024 and continues to face substantial doubt about its ability to continue as a going concern.

RetinalGenix Technologies reported a net loss of $2.146 million for the first quarter of 2024 and highlighted substantial doubt about its ability to continue as a going concern.